ARCHIVES

How ImClone’s “Hot” New Drug Got Cold Shoulder From FDA

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Kansas City Clinic Settles Medicare Overbilling Claim

June 6, 2014

NCI-Approved Clinical Trials

August 25, 2006

Also in this 8-page issue: FDA begins search for director of new Office of Oncology Drug Products.

October 8, 2004

Decision Delayed On Breast Cancer Study Until After Consensus Meeting

July 5, 1985

In Brief: Outstanding Investigator Awards Draw 150 Letters Of Intent; Applications Due July 15

June 15, 1984

Two Breast Cancer Screening Methods Found Equivalent

August 29, 2008